73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
'3D mammography' almost halves the incidence of breast cancer between two screening tests in clinical trial

'3D mammography' almost halves the incidence of breast cancer between two screening tests in clinical trial

byUniversity of CórdobaDBT interval carcinoma. A 60-year-old asymptomatic patient who underwent a repeat mammographic study 20months after the screening study interpreted as normal due to

'3D mammography' almost halves the incidence of breast cancer between two screening tests in clinical trial

byUniversity of CórdobaDBT interval carcinoma. A 60-year-old asymptomatic patient who underwent a repeat mammographic study 20months after the screening study interpreted as normal due to
Study discusses liquid biopsy as a game changer for early lung cancer detection

Study discusses liquid biopsy as a game changer for early lung cancer detection

by Cactus CommunicationsCredit: CC0 Public DomainIn 2020, 1.8 million people succumbed to lung cancer. The late-stage discovery of lung cancer is one of the glaring challenges faced by the medical com

Study discusses liquid biopsy as a game changer for early lung cancer detection

by Cactus CommunicationsCredit: CC0 Public DomainIn 2020, 1.8 million people succumbed to lung cancer. The late-stage discovery of lung cancer is one of the glaring challenges faced by the medical com
New research results explore the safety of short-term cultivated CAR T cells in cancer immunotherapy

New research results explore the safety of short-term cultivated CAR T cells in cancer immunotherapy

by Susanne Stöcker, Paul-Ehrlich-Institut - Bundesinstitut für Impfstoffe und biomedizinische ArzneimittelTo make CAR T cells available to all patients, various strategies facilitating the manufacturi

New research results explore the safety of short-term cultivated CAR T cells in cancer immunotherapy

by Susanne Stöcker, Paul-Ehrlich-Institut - Bundesinstitut für Impfstoffe und biomedizinische ArzneimittelTo make CAR T cells available to all patients, various strategies facilitating the manufacturi
Delayed treatment effect predicting (DTEP) model found to enhance precision in immuno-oncology trial designs

Delayed treatment effect predicting (DTEP) model found to enhance precision in immuno-oncology trial designs

by Science China PressAt the trial design stage, by inputting information on treatment stage, cancer type, and experimental and control arm regimens, investigators can utilize the nomogram or web

Delayed treatment effect predicting (DTEP) model found to enhance precision in immuno-oncology trial designs

by Science China PressAt the trial design stage, by inputting information on treatment stage, cancer type, and experimental and control arm regimens, investigators can utilize the nomogram or web
Hypofractioned post-prostatectomy radiotherapy new acceptable practice standard based on NRG Oncology trial findings

Hypofractioned post-prostatectomy radiotherapy new acceptable practice standard based on NRG Oncology trial findings

by NRG OncologyResults from the Phase III NRG Oncology NRG-GU003 clinical trial comparing hypofractioned post-prostatectomy radiotherapy (HYPORT) to conventionally fractioned post-prostatectomy radiot

Hypofractioned post-prostatectomy radiotherapy new acceptable practice standard based on NRG Oncology trial findings

by NRG OncologyResults from the Phase III NRG Oncology NRG-GU003 clinical trial comparing hypofractioned post-prostatectomy radiotherapy (HYPORT) to conventionally fractioned post-prostatectomy radiot
Immunotherapy targeting cancer fusion protein may hold key to treating rare liver cancer

Immunotherapy targeting cancer fusion protein may hold key to treating rare liver cancer

by St. Jude Children's Research HospitalCredit: Unsplash/CC0 Public DomainFibrolamellar carcinoma (FLC) is a rare liver cancer with a poor prognosis if not addressed early with surgery. The d

Immunotherapy targeting cancer fusion protein may hold key to treating rare liver cancer

by St. Jude Children's Research HospitalCredit: Unsplash/CC0 Public DomainFibrolamellar carcinoma (FLC) is a rare liver cancer with a poor prognosis if not addressed early with surgery. The d
AI-based app can help physicians find skin melanoma

AI-based app can help physicians find skin melanoma

by Karin Söderlund,Swedish Research CouncilGraph showing the relationships between the primary care physicians' (PCPs') reported degree of melanoma suspicion, final tumor diagnosis and t

AI-based app can help physicians find skin melanoma

by Karin Söderlund,Swedish Research CouncilGraph showing the relationships between the primary care physicians' (PCPs') reported degree of melanoma suspicion, final tumor diagnosis and t
Genetically engineered dendritic cells enhance the power of immunotherapy against lung cancer

Genetically engineered dendritic cells enhance the power of immunotherapy against lung cancer

by Denise Heady,University of California, Los AngelesGraphical Abstract. Credit:Cell Reports Medicine(2024). DOI: 10.1016/j.xcrm.2024.101479A study by researchers at the UCLA Health

Genetically engineered dendritic cells enhance the power of immunotherapy against lung cancer

by Denise Heady,University of California, Los AngelesGraphical Abstract. Credit:Cell Reports Medicine(2024). DOI: 10.1016/j.xcrm.2024.101479A study by researchers at the UCLA Health
Survival 21 percent a year after ICU discharge for blood cancer patients

Survival 21 percent a year after ICU discharge for blood cancer patients

by Elana GotkineFor hematologic malignancy (HM) patients admitted to the intensive care unit (ICU), survival is 49 percent at seven days and 21 percent at 12 months, according to a study published onl

Survival 21 percent a year after ICU discharge for blood cancer patients

by Elana GotkineFor hematologic malignancy (HM) patients admitted to the intensive care unit (ICU), survival is 49 percent at seven days and 21 percent at 12 months, according to a study published onl
New bioinformatics tool to identify chromosomal alterations in tumor cells

New bioinformatics tool to identify chromosomal alterations in tumor cells

by University of BarcelonaRepresentative output image generated by QATS in which two toroidal nuclei (in magenta) and four micronuclei (in green) were identified. Credit:Bioinformatics&nbsp

New bioinformatics tool to identify chromosomal alterations in tumor cells

by University of BarcelonaRepresentative output image generated by QATS in which two toroidal nuclei (in magenta) and four micronuclei (in green) were identified. Credit:Bioinformatics&nbsp
Why do cancer patients lose weight? Study points to elevated lactate levels

Why do cancer patients lose weight? Study points to elevated lactate levels

byNature Publishing GroupSchematic illustration depicting the signaling cascade downstream of lactate/GPR81 in promoting cancer cachexia. Credit:Nature Metabolism(2024). DOI: 10.1038

Why do cancer patients lose weight? Study points to elevated lactate levels

byNature Publishing GroupSchematic illustration depicting the signaling cascade downstream of lactate/GPR81 in promoting cancer cachexia. Credit:Nature Metabolism(2024). DOI: 10.1038
Lu(a)minar flow odyssey—using the power of water and light in early leukemia diagnostics

Lu(a)minar flow odyssey—using the power of water and light in early leukemia diagnostics

by Polish Academy of SciencesOpto-hydrodynamic tweezers. (a) and (b) Schematic illustrations of the top view and side view of OHT, respectively, along with the major various forces acting on the

Lu(a)minar flow odyssey—using the power of water and light in early leukemia diagnostics

by Polish Academy of SciencesOpto-hydrodynamic tweezers. (a) and (b) Schematic illustrations of the top view and side view of OHT, respectively, along with the major various forces acting on the